新型长效胰岛素Gla-300的研究与临床应用 ㊃综述㊃ 通信作者:杜云鹏,E m a i l :d u y u n p e n g 001@126.c o m 新型长效胰岛素G l a -300的研究与临床应用杜云鹏1,邓俊刚1,谢英毅2 (1.桂林医学院附属医院药剂科,广西桂林541000;2.贵港市中西医结合骨科医院药剂科,广西贵港537100 ) 摘...
Main prev. BI was insulin glargine 100 U/mL (41.2%), most common oral therapy was metformin ± DPP-4 inhibitor (52.9%). At 12 months, proportion of pts at A1c target in BBT (n=446) was highest in pts previously on NPH insulin (n=84; 45.2%). Pts on BOTplus (n=82) achieved ...
We analyzed data from PWT2D uncontrolled on prior basal insulin (BI) , 1282 switching from NPH and 2899 from other non-NPH BIs (mainly glargine 100 U/mL, 67%) to Gla-300. In the NPH group, mean±SD age was 63±9.4 years, BMI 32.5±5.8 kg/m2, and median diabetes duration 12 ...
IDeg-100 in insulin-nave people with T2DM 卤 GLP-1 RA.doi:10.2337/db18-1032-PGEREMIA B. BOLLIALICE CHENGZSOLT BOSNYAKEMMANUELLE BOELLE-LE CORFECANNA M. CALIXIANGLING WANGJUAN P. FRIASRONAN ROUSSELJULIO ROSENSTOCKDiabetes
insulinpenBackground: To deliver insulin glargine 300 U/mL (Gla-300), the widely used SoloSTAR® pen has been modified to allow for accurate and precise delivery of required insulin units in one-third of the volume compared with insulin glargine 100 U/mL, while improving usability. Here ...
In this ORION study subgroup analysis, the safety and effectiveness of insulin glargine 300 U/mL (Gla-300) was evaluated in people from the South Asia region with type 2 diabetes mellitus (T2DM) before, during, and after Ramadan, in a real-world setting.The ORION study was a real-world,...
743-P: Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Insulin-Nave People with Type 2 Diabetes (T2DM) and Renal Impairment (RI): A Subgroup Analysis of the ATOS StudyBasal insulinGlycaemic controlHypoglycaemia...
Safety and efficacy of insulin glargine 300 U/ml (Gla-300) compared with other basal insulin therapies in patients with type 2 diabetes mellitus (T2DM): a network meta-analysis (NMA) [abstract 99OR]. Diabetes. 2015;64(suppl 1):A26....
In PWD2 inadequately controlled with GLP-1 RA therapy, addition of basal insulin is recommended. We used a US electronic medical record data source (IBM Explorys) of ~4 million PWD2 to assess the real-world impact of adding the basal insulin analog Gla-300 to GLP-1RA t...
insulin glarginepatient self-reportarterial thoracic outlet syndromePatients' satisfaction is a key determinant of treatment adherence and persistence, for optimal management of T2D. ATOS, a 12-month prospective observational study conducted in Asia, Middle East, North Africa, Latin America, and Eastern...